中文
English
한국어
日本語
Español
Français
Русский
| カタログ番号 | AV064018 |
|---|---|
| 説明 |
Anti-Omalizumab ELISA Kit (AV064018) — Quantitative sandwich ELISA for Anti-Omalizumab. Sample: Plasma, Serum. Range: 156.25 - 10, 000 ng/mL.
Highlights
|
| サンプルタイプ | Plasma, Serum |
| 感度 | 0.25 ng/mL |
| レンジ | 156.25 - 10, 000 ng/mL |
| アクセッション番号 | CAS: 242138-07-4 |
| アプリケーション | ELISA |
| 検出方法 | Colorimetric |
| アッセイタイプ | Quantitative |
| 回収率 | 80-120% |
| 発送 | 2-8 ℃ |
| 安定性と保存 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 仕様 | Omalizumab |
| 別名 | IGE25, olizumab, pSVIE26, rhuMab-E25, 242138-07-4 |
| 背景 | Immunoglobulin heavy constant epsilon (Omalizumab) is a ~59 kDa protein. Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. 1. Schroeder, HW. et al. (2010) The Journal of allergy and clinical immunology 125, S41-52. PMID: 20176268 2. McHeyzer-Williams, M. et al. (2011) Nature reviews. Immunology 12, 24-34. PMID: 22158414 3. Teng, G. et al. (2007) Annual review of genetics 41, 107-20. PMID: 17576170 |
| 注意事項 | For Research Use Only. |
Standard Curve of Anti-Omalizumab ELISA Kit
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
